Interim report 2025, January 1–June 30
In the second quarter of 2025, organic sales adjusted for currency effects increased, driven by steady demand for laboratory equipment and rental of equipment for clinical studies. Operating cash flow improved in the quarter, and EBITA was in line with last year with a stronger margin. Through the new capital structure, ADDvise’s annual interest expenses are expected to decrease by approximately SEK 56 million, which provides good conditions for continued growth. April–June 2025 Net revenue was SEK 396.1 million (412.3), an organic decrease of 3.9%, an organic increase of 3.8% net of